Real-world analysis of inetetamab combined with pyrotinib plus chemotherapy for the treatment of HER2-positive advanced breast cancer: A multi-center retrospective study.

被引：0
|
作者：
Zhou, Huanhuan
Chen, Zhanhong
Deng, Chao
Gan, Lu
Li, Fan
Xu, Xuefeng
Fang, YanMan
Qi, Xiaowei
Bian, Wei Gang
Yu, Zeshun
Wang, Xiaojia
机构：
[1] Zhejing Canc Hosp, Hangzhou, Peoples R China
[2] Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Breast Canc Ctr, Hangzhou, Peoples R China
[3] ChongQing Univ, Ctr Canc, Gorges Hosp 3, Chongqing, Peoples R China
[4] Chongqing Med Univ, Hosp 1, Affiliated Hosp, Chongqing, Peoples R China
[5] Zhangjiakou First Hosp, Zhangjiakou, Hebei, Peoples R China
[6] Guiyang Maternal & Child Hlth Hosp, Guiyang, Peoples R China
[7] Army Med Univ, Southwest Hosp, Dept Breast & Thyroid Surg, Chongqing, Peoples R China
[8] Chongqing Municipal Hlth Commiss, Key Lab Minimally Invas Surg & Precis Treatment B, Chongqing, Chongqing, Peoples R China
[9] Yancheng First Peoples Hosp, Yancheng, Peoples R China
[10] Binzhou Med Univ Hosp, Binzhou, Peoples R China
[11] Zhejiang Canc Hosp, Hangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13012
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A multicenter, retrospective, real-world study of inetetamab combined with pyrotinib and vinorelbine as treatment for HER2-positive metastatic breast cancer
    Jin, N.
    Yin, Y.
    Li, W.
    Huang, X.
    ANNALS OF ONCOLOGY, 2023, 34 : S1492 - S1492
  • [2] A Multicenter, Retrospective, Real World Study of Inetetamab Combined with Pyrotinib and Vinorelbine as Treatment for HER2-positive Metastatic Breast Cancer
    Yin, Yongmei
    Li, Wei
    Huang, Xiang
    Jin, Nan
    Wu, Xinyu
    Sun, Chunxiao
    Hua, Yijia
    CANCER RESEARCH, 2024, 84 (09)
  • [3] Real-world efficacy and safety of inetetamab-based therapy in patients with HER2-positive metastatic breast cancer with prior trastuzumab exposure: A multi-center retrospective study.
    Duan, Yangyang
    Sun, Tao
    Chen, Zhanhong
    Ouyang, Quchang
    Li, Kai
    Yan, Min
    Lv, Zheng
    Li, Zhaohui
    Man, Li
    Luo, Xu
    Dong, Yuyang
    Jing, Mingxi
    Wang, Yan
    Guo, Xiangyu
    Xu, Junnan
    Li, Xiaorui
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] Pyrotinib in the Treatment of Women With HER2-Positive Advanced Breast Cancer: A Multicenter, Prospective, Real-World Study
    Zhang, Lili
    Wu, Xiaohong
    Zhou, Jun
    Zhu, Mingzhen
    Yu, Hao
    Zhang, Yusong
    Zhao, Yutian
    Han, Zhengxiang
    Guo, Yujiang
    Guan, Xiaoqing
    Wang, Xufen
    Xu, Hong
    Sun, Li
    Zhang, Jiaxin
    Zhuang, Min
    Xie, Li
    Yu, Shiyou
    Chen, Ping
    Feng, Jifeng
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [5] Inetetamab-based therapy in real-world treatment patterns with HER2-positive advanced breast cancer patients: a retrospective single-center study
    Jiang, Mingxia
    Liu, Jiaxuan
    He, Maiyue
    Zhang, Mengqi
    Zhou, Shihan
    Chen, Shanshan
    Cai, Ruigang
    Mo, Hongnan
    Lan, Bo
    Zhang, Pin
    Xu, Binghe
    Li, Qiao
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [6] Real-World data of triplet combination of trastuzumab, lapatinib and chemotherapy in HER2-positive metastatic breast cancer: A multi-center retrospective study
    Li, Y.
    Gong, C.
    Lu, Q.
    Zhou, Z.
    Luo, T.
    Li, W.
    Li, G.
    Ge, R.
    Wang, B.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S66 - S66
  • [7] Pyrotinib in the treatment of women with advanced HER2 positive breast cancer: A multicenter, prospective, real-world study.
    Feng, Jifeng
    Zhang, Lili
    Wu, Xiaohong
    Zhou, Jun
    Zhu, Mingzhen
    Zhang, Yusong
    Yu, Hao
    Han, Zhengxiang
    Guo, Yujiang
    Guan, Xiaoqing
    Wang, Xufen
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] Pyrotinib-based therapy for patients with HER2-positive breast cancer: A multicenter, real-world study.
    Wang, Haoqi
    Liu, Yueping
    Yang, Hua
    Wang, Shuaibing
    Cui, Guozhong
    Ma, Jie
    Liu, Yunjiang
    Li, Xianqiao
    Luo, Ruizhen
    Zhang, Wei
    Geng, Cuizhi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [9] Real-world data of triplet combination of pyrotinib, trastuzumab, and chemotherapy in HER2-positive metastatic breast cancer: a multicenter, retrospective study
    You, Shuhui
    Sang, Die
    Xu, Fei
    Luo, Ting
    Yuan, Peng
    Xie, Yizhao
    Wang, Biyun
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [10] REAL-WORLD DATA OF TRIPLET COMBINATION OF PYROTINIB, TRASTUZUMAB, AND CHEMOTHERAPY IN HER2-POSITIVE METASTATIC BREAST CANCER: A MULTICENTER, RETROSPECTIVE STUDY
    Wang, Biyun
    You, Shuhui
    Xie, Yizhao
    Sang, Die
    Xu, Fei
    Luo, Ting
    Yuan, Peng
    BREAST, 2023, 71 : S52 - S52
12345